The Ensign Group (ENSG)
(Delayed Data from NSDQ)
$152.03 USD
-1.64 (-1.07%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $152.09 +0.06 (0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$152.03 USD
-1.64 (-1.07%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $152.09 +0.06 (0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum B VGM
Zacks News
Brookdale (BKD) Reports Occupancy Growth for 20 Straight Months
by Zacks Equity Research
The continuous uptick observed in Brookdale's (BKD) weighted average occupancy level is expected to inflict a favorable impact on its resident fee revenues in the days ahead.
Molina (MOH) to Buy Bright Health's California Medicare Business
by Zacks Equity Research
Molina's (MOH) Brand New Day and Central Health Plan of California buyout complements Molina's Medicaid footprint and aligns with its 2024 Medi-Cal plan.
Ensign Group (ENSG) Up 26% in a Year: More Room to Run?
by Zacks Equity Research
Ensign Group (ENSG) is well-poised for growth on the back of an aging U.S. population, an expanding healthcare portfolio and prudent deployment of capital.
UnitedHealth Group (UNH) Expands Home Healthcare Business
by Zacks Equity Research
UnitedHealth Group (UNH) boosts home healthcare presence with the acquisition of Amedisys for $3.3 billion
Zacks.com featured highlights Terex, Caterpillar and Ensign
by Zacks Equity Research
Terex, Caterpillar and Ensign have been highlighted in this Screen of The Week article.
UnitedHealth's (UNH) Optum Rx Makes Patient Care Affordable
by Zacks Equity Research
UnitedHealth Group, Inc's. (UNH) Optum Rx is set to offer three biosimilar alternatives for HUMIRA effective Jul 1, providing affordability in patient care.
3 Stocks Worth a Buy for Solid Earnings Growth in 2H 2023
by Tirthankar Chakraborty
Invest in stocks like Terex (TEX), Caterpillar (CAT) & Ensign Group (ENSG), as of now, for superb earnings growth.
Why Ensign Group (ENSG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
UnitedHealth's (UNH) Program to Aid Georgia's Diabetic Patients
by Zacks Equity Research
UnitedHealth's (UNH) unit, UnitedHealthcare, extends its community-based program to improve the health conditions of Southwest Georgia's diabetic patients.
Are Investors Undervaluing The Ensign Group (ENSG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Encompass Health's (EHC) 158th Hospital Opens in Maryland
by Zacks Equity Research
The Rehabilitation Hospital of Bowie is Encompass Health's (EHC) second location in the state of Maryland.
Centene (CNC) to Provide Managed Care for SoonerSelect Program
by Zacks Equity Research
Centene (CNC) wins managed care contract to serve people in Oklahoma through the SoonerSelect and SoonerSelect Children's Specialty Plan programs.
UnitedHealth Group (UNH) Hikes Quarterly Dividend by 14%
by Zacks Equity Research
UnitedHealth Group's (UNH) recent dividend hike highlights a solid financial position and efforts to sustain its sound capital deployment history.
Here's Why Investors Should Hold Universal Health (UHS) Now
by Zacks Equity Research
Universal Health (UHS) benefits from growing patient volumes, sound segmental performance and a solid capital position.
Ensign Group (ENSG) Down 7.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Factors That Make Ensign Group (ENSG) a Lucrative Bet Now
by Zacks Equity Research
Ensign Group (ENSG) is well-poised for growth on increasing service revenues, an expanding healthcare portfolio and a strong capital position.
Is The Ensign Group (ENSG) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Ensign Group (ENSG) is Poised for a Turnaround After Losing -7.68% in 4 Weeks
by Zacks Equity Research
Ensign Group (ENSG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SLYG
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPSM
Ensign Group (ENSG) Beats on Q1 Earnings, Hikes '23 EPS View
by Zacks Equity Research
Ensign Group's (ENSG) first-quarter results benefit from growing skilled services revenues. Management estimates EPS of $4.64-$4.77 for this year, higher than the earlier mentioned $4.60-$4.74.
Ensign Group (ENSG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 2.73% and 4.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.